Variant #0000987802 (NC_000017.10:g.3543522_3543523del, NM_001031681.2:c.22_23del (CTNS))
| Individual ID |
00451648 |
| Chromosome |
17 |
| Allele |
Maternal (confirmed) |
| Affects function (as reported) |
Probably affects function |
| Affects function (by curator) |
Not classified |
| Classification method |
ACMG |
| Clinical classification |
likely pathogenic (recessive) |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.3543522_3543523del |
| DNA change (hg38) |
g.3640228_3640229del |
| Published as |
- |
| ISCN |
- |
| DB-ID |
CTNS_000042 See all 2 reported entries |
| Variant remarks |
This variant that is responsible of 'Cystinosis, nephropathic', was identified in co-occurrence with the COL4A5 heterozygous pathogenic variant NM_033380.3:c.3088G>A, p.Gly1030Ser, causing Alport syndrome 1. This variant was confirmed by Sanger sequencing in patient and tested in parents (maternal confirmed) |
| Reference |
- |
| ClinVar ID |
- |
| dbSNP ID |
rs758995279 |
| Origin |
Germline |
| Segregation |
yes |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
Retrieve |
| Owner |
Miriam Erandi Reyna-Fabián |
| Database submission license |
Creative Commons Attribution-ShareAlike 4.0 International |
| Created by |
Miriam Erandi Reyna-Fabián |
| Date created |
2024-06-20 21:11:40 +02:00 (CEST) |
| Date last edited |
2024-06-28 10:30:21 +02:00 (CEST) |

Variant on transcripts
Screenings
|